AMSL.N0000 Stock Overview
Operates a two-tier hospital in Sri Lanka. More details
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 5/6 |
Financial Health | 4/6 |
Dividends | 2/6 |
Asiri Surgical Hospital PLC Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | LK₨10.90 |
52 Week High | LK₨13.30 |
52 Week Low | LK₨10.50 |
Beta | 0.46 |
11 Month Change | -0.91% |
3 Month Change | -4.39% |
1 Year Change | -14.84% |
33 Year Change | -31.87% |
5 Year Change | 5.83% |
Change since IPO | 319.23% |
Recent News & Updates
Recent updates
Shareholder Returns
AMSL.N0000 | LK Healthcare | LK Market | |
---|---|---|---|
7D | -0.9% | 0.9% | -0.3% |
1Y | -14.8% | -22.9% | 19.1% |
Return vs Industry: AMSL.N0000 exceeded the LK Healthcare industry which returned -22.9% over the past year.
Return vs Market: AMSL.N0000 underperformed the LK Market which returned 19.1% over the past year.
Price Volatility
AMSL.N0000 volatility | |
---|---|
AMSL.N0000 Average Weekly Movement | 4.5% |
Healthcare Industry Average Movement | 5.0% |
Market Average Movement | 4.3% |
10% most volatile stocks in LK Market | 6.5% |
10% least volatile stocks in LK Market | 3.0% |
Stable Share Price: AMSL.N0000 has not had significant price volatility in the past 3 months compared to the LK market.
Volatility Over Time: AMSL.N0000's weekly volatility (4%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2000 | n/a | Karunamuni Manjula Karunaratne | asirihealth.com/surgical-home |
Asiri Surgical Hospital PLC operates a two-tier hospital in Sri Lanka. It operates through Pre Care, Post Care, and Pharmaceutical segments. The company offers heart, brain and spine, bone marrow transplant, stroke, interventional radiology, mother and baby care, kidney transplant, urology, cancer, IVF and fertility, and wellness centers.
Asiri Surgical Hospital PLC Fundamentals Summary
AMSL.N0000 fundamental statistics | |
---|---|
Market cap | LK₨5.76b |
Earnings (TTM) | LK₨622.39m |
Revenue (TTM) | LK₨6.81b |
9.3x
P/E Ratio0.8x
P/S RatioIs AMSL.N0000 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
AMSL.N0000 income statement (TTM) | |
---|---|
Revenue | LK₨6.81b |
Cost of Revenue | LK₨4.05b |
Gross Profit | LK₨2.76b |
Other Expenses | LK₨2.14b |
Earnings | LK₨622.39m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 1.18 |
Gross Margin | 40.52% |
Net Profit Margin | 9.14% |
Debt/Equity Ratio | 48.7% |
How did AMSL.N0000 perform over the long term?
See historical performance and comparison